Entero Healthcare Solutions holds 8th AGM on August 19, 2026
NiveshIQ
NSE: ENTERO · Healthcare
Entero Healthcare Solutions Ltd.
₹1,222.20▼ ₹13.60 (-1.10%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ENTERO. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited is a leading Indian healthcare company that engages in the distribution and marketing of pharmaceutical, surgical products, and allied services. The company's core business is driven by the distribution of generic formulations, active pharmaceutical ingredients, and surgical consumables, among other products. Entero Healthcare Solutions has reported a significant revenue growth of 29.3% in FY26, with a turnover of ₹6,591 crore. The company's net profit has also risen by 36% in FY26, with a net income of ₹115 crore. Entero Healthcare Solutions has a strong competitive position in the Indian healthcare market, with a diverse product portfolio and a wide reach across hospitals, retail pharmacies, and healthcare clinics. The company's growth outlook is promi
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,922 Cr +128.60% | ₹5,096 Cr +29.90% | ₹6,591 Cr +29.30% |
| EBITDA Margin | 2.88% | 3.36% | 4.33% |
| Net Profit | ₹39.00 Cr | ₹107.00 Cr +174.40% | ₹154.02 Cr +43.90% |
| EPS | ₹27.41 | ₹21.81 | ₹26.44 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Entero Healthcare reports ₹6591 crore turnover in FY26 BRSR filing
Entero Healthcare reports ₹6591 crore turnover in FY26 BRSR filing
🔒
+ 3 more stories about Entero Healthcare Solutions Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 910 Cr, PAT ₹28 Cr, EPS ₹6.44, EBITDA margin 1.7%. Growth context: revenue YoY +42.6%, PAT YoY -9.6%, revenue QoQ +11.9%, PAT QoQ -17.6%. Street verdict: inline, revenue surprise +1.7%, PAT surprise -2.6%.
Management's near-term growth strategy hinges on product launches, approvals, and therapy-mix improvement, with successf...
FY26 (last completed FY): revenue ₹6, 591 Cr, PAT ₹154 Cr, EBITDA margin 4.3%, EPS ₹26.44. Year-on-year: revenue YoY +29...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ENTERO
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ENTERO alongside your other holdings
Unlock full ENTERO research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Entero Healthcare Solutions Ltd.?
NiveshIQ detects active intelligence signals for Entero Healthcare Solutions Ltd. (ENTERO) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Entero Healthcare Solutions Ltd.?
Entero Healthcare Solutions Ltd. operates in the Healthcare sector with a market capitalisation of ₹531,268.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.